1. Stocks
  2. Sonnet BioTherapeutics Holdings Inc
  3. Swot
swot-logo

Sonnet BioTherapeutics Holdings Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Sonnet BioTherapeutics Holdings Inc has 11 Strengths, 12 Weaknesses, 3 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Relative Outperformance versus Industry over 1 Week

Significant (over 30%) distance from 52 week high

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Annual Net Profits improving for last 2 years

Stock with Low PE (PE < = 10)

Volume Shockers

Highest Recovery from 52 Week Low

Stocks with Quarter Change % less than Industry

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Lowest Momentum Scores (Technical Scores)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Highest fall from 52 Week High

Top Losers

Low Piotroski Score : Companies with weak financials

Declining Net Cash Flow : Companies not able to generate net cash

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts

Institutions increasing their shareholding

MFs increased their shareholding last quarter